Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Handa, K; Jacobs, F; Longenecker, BM; Hakomori, S
   Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note (vol 285, pg 788, 2001)
   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
   
   K. Handa et al., "Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note (vol 285, pg 788, 2001)", BIOC BIOP R, 286(4), 2001, pp. 839-839
2. Handa, K; Jacobs, F; Longenecker, BM; Hakomori, S
   Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note
   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
   
   K. Handa et al., "Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note", BIOC BIOP R, 285(3), 2001, pp. 788-794
3. Moase, EH; Qu, W; Ishida, T; Gabos, Z; Longenecker, BM; Zimmermann, GL; Ding, L; Krantz, M; Allen, TM
   Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
   
   E.H. Moase et al., "Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer", BBA-BIOMEMB, 1510(1-2), 2001, pp. 43-55
4. Zimmermann, GL; Krantz, MJ; Kane, KP; Longenecker, BM
   A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells
   CANCER IMMUNOLOGY IMMUNOTHERAPY
   
   G.L. Zimmermann et al., "A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells", CANCER IMMU, 49(6), 2000, pp. 305-313
5. Schuman, J; Qiu, DX; Koganty, RR; Longenecker, BM; Campbell, AP
   Glycosylations versus conformational preferences of cancer associated mucin core
   GLYCOCONJUGATE JOURNAL
   
   J. Schuman et al., "Glycosylations versus conformational preferences of cancer associated mucin core", GLYCOCON J, 17(12), 2000, pp. 835-848
6. Holmberg, LA; Oparin, DV; Gooley, T; Lilleby, K; Bensinger, W; Reddish, MA; MacLean, GD; Longenecker, BM; Sandmaier, BM
   Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine
   BONE MARROW TRANSPLANTATION
   
   L.A. Holmberg et al., "Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine", BONE MAR TR, 25(12), 2000, pp. 1233-1241
7. Sandmaier, BM; Oparin, DV; Holmberg, LA; Reddish, MA; MacLean, GD; Longenecker, BM
   Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine
   JOURNAL OF IMMUNOTHERAPY
   
   B.M. Sandmaier et al., "Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine", J IMMUNOTH, 22(1), 1999, pp. 54-66
8. Ragupathi, G; Howard, L; Cappello, S; Koganty, RR; Qiu, DX; Longenecker, BM; Reddish, MA; Lloyd, KO; Livingston, PO
   Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells
   CANCER IMMUNOLOGY IMMUNOTHERAPY
   
   G. Ragupathi et al., "Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells", CANCER IMMU, 48(1), 1999, pp. 1-8
9. Hwang, IR; Nahm, DH; Cho, SN; Longenecker, BM; Koganty, RR; Park, IS
   Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer
   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
   
   I.R. Hwang et al., "Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer", J CANC RES, 125(10), 1999, pp. 582-587
10. AGRAWAL B; GENDLER SJ; LONGENECKER BM
    THE BIOLOGICAL ROLE OF MUCINS IN CELLULAR INTERACTIONS AND IMMUNE REGULATION - PROSPECTS FOR CANCER-IMMUNOTHERAPY
    Molecular medicine today
    
    B. Agrawal et al., "THE BIOLOGICAL ROLE OF MUCINS IN CELLULAR INTERACTIONS AND IMMUNE REGULATION - PROSPECTS FOR CANCER-IMMUNOTHERAPY", Molecular medicine today, 4(9), 1998, pp. 397-403
11. AGRAWAL B; KRANTZ MJ; REDDISH MA; LONGENECKER BM
    CANCER-ASSOCIATED MUC1 MUCIN INHIBITS HUMAN T-CELL PROLIFERATION, WHICH IS REVERSIBLE BY IL-2
    Nature medicine
    
    B. Agrawal et al., "CANCER-ASSOCIATED MUC1 MUCIN INHIBITS HUMAN T-CELL PROLIFERATION, WHICH IS REVERSIBLE BY IL-2", Nature medicine, 4(1), 1998, pp. 43-49
12. GUAN HH; BUDZYNSKI W; KOGANTY RR; KRANTZ MJ; REDDISH MA; ROGERS JA; LONGENECKER BM; SAMUEL J
    LIPOSOMAL FORMULATIONS OF SYNTHETIC MUC1 PEPTIDES - EFFECTS OF ENCAPSULATION VERSUS SURFACE DISPLAY OF PEPTIDES ON IMMUNE-RESPONSES
    Bioconjugate chemistry
    
    H.H. Guan et al., "LIPOSOMAL FORMULATIONS OF SYNTHETIC MUC1 PEPTIDES - EFFECTS OF ENCAPSULATION VERSUS SURFACE DISPLAY OF PEPTIDES ON IMMUNE-RESPONSES", Bioconjugate chemistry, 9(4), 1998, pp. 451-458
13. REDDISH MA; SURESH MR; KOGANTY RR; FORTIER S; BARONIC L; BERG A; MICHAEL B; LONGENECKER BM
    ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/
    Tumor biology
    
    M.A. Reddish et al., "ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/", Tumor biology, 19, 1998, pp. 57-66
14. Agrawal, B; Krantz, MJ; Reddish, MA; Longenecker, BM
    Rapid induction of primary human CD4(+) and CD8(+) T cell responses against cancer-associated MUC1 peptide epitopes
    INTERNATIONAL IMMUNOLOGY
    
    B. Agrawal et al., "Rapid induction of primary human CD4(+) and CD8(+) T cell responses against cancer-associated MUC1 peptide epitopes", INT IMMUNOL, 10(12), 1998, pp. 1907-1916
15. OGATA S; KOGANTY R; REDDISH M; LONGENECKER BM; CHEN AL; PEREZ C; ITZKOWITZ SH
    DIFFERENT MODES OF SIALYL-TN EXPRESSION DURING MALIGNANT TRANSFORMATION OF HUMAN COLONIC MUCOSA
    Glycoconjugate journal
    
    S. Ogata et al., "DIFFERENT MODES OF SIALYL-TN EXPRESSION DURING MALIGNANT TRANSFORMATION OF HUMAN COLONIC MUCOSA", Glycoconjugate journal, 15(1), 1998, pp. 29-35
16. REDDISH MA; MACLEAN GD; KOGANTY RR; KANMITCHELL J; JONES V; MITCHELL MS; LONGENECKER BM
    ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE
    International journal of cancer
    
    M.A. Reddish et al., "ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE", International journal of cancer, 76(6), 1998, pp. 817-823
17. SAMUEL J; BUDZYNSKI WA; REDDISH MA; DING L; ZIMMERMANN GL; KRANTZ MJ; KOGANTY RR; LONGENECKER BM
    IMMUNOGENICITY AND ANTITUMOR-ACTIVITY OF A LIPOSOMAL MUC1 PEPTIDE-BASED VACCINE
    International journal of cancer
    
    J. Samuel et al., "IMMUNOGENICITY AND ANTITUMOR-ACTIVITY OF A LIPOSOMAL MUC1 PEPTIDE-BASED VACCINE", International journal of cancer, 75(2), 1998, pp. 295-302
18. AGRAWAL B; REDDISH MA; CHRISTIAN B; VANHEELE A; TANG L; KOGANTY RR; LONGENECKER BM
    THE ANTI-MUC1 MONOCLONAL-ANTIBODY BCP8 CAN BE USED TO ISOLATE AND IDENTIFY PUTATIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ASSOCIATED AMINO-ACID-SEQUENCES
    Cancer research
    
    B. Agrawal et al., "THE ANTI-MUC1 MONOCLONAL-ANTIBODY BCP8 CAN BE USED TO ISOLATE AND IDENTIFY PUTATIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ASSOCIATED AMINO-ACID-SEQUENCES", Cancer research, 58(22), 1998, pp. 5151-5156
19. AGRAWAL B; KRANTZ MJ; PARKER J; LONGENECKER BM
    EXPRESSION OF MUC1 MUCIN ON ACTIVATED HUMAN T-CELLS - IMPLICATIONS FOR A ROLE OF MUC1 IN NORMAL IMMUNE REGULATION
    Cancer research
    
    B. Agrawal et al., "EXPRESSION OF MUC1 MUCIN ON ACTIVATED HUMAN T-CELLS - IMPLICATIONS FOR A ROLE OF MUC1 IN NORMAL IMMUNE REGULATION", Cancer research, 58(18), 1998, pp. 4079-4081
20. Kam, JL; Regimbald, LH; Hilgers, JHM; Hoffman, P; Krantz, MJ; Longenecker, BM; Hugh, JC
    MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 andMUC1 binding requires six tandem repeats
    CANCER RESEARCH
    
    J.L. Kam et al., "MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 andMUC1 binding requires six tandem repeats", CANCER RES, 58(23), 1998, pp. 5577-5581
21. MACLEAN GD; REDDISH MA; LONGENECKER BM
    PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS
    Journal of immunotherapy with emphasis on tumor immunology
    
    G.D. Maclean et al., "PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS", Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 70-78
22. REDDISH MA; JACKSON L; KOGANTY RR; QIU DX; HONG W; LONGENECKER BM
    SPECIFICITIES OF ANTI-SIALYL-TN AND ANTI-TN MONOCLONAL-ANTIBODIES GENERATED USING NOVEL CLUSTERED SYNTHETIC GLYCOPEPTIDE EPITOPES
    Glycoconjugate journal
    
    M.A. Reddish et al., "SPECIFICITIES OF ANTI-SIALYL-TN AND ANTI-TN MONOCLONAL-ANTIBODIES GENERATED USING NOVEL CLUSTERED SYNTHETIC GLYCOPEPTIDE EPITOPES", Glycoconjugate journal, 14(5), 1997, pp. 549-560
23. KOGANTY RR; REDDISH MA; LONGENECKER BM
    GLYCOPEPTIDE-BASED AND CARBOHYDRATE-BASED SYNTHETIC VACCINES FOR THE IMMUNOTHERAPY OF CANCER
    Drug discovery today
    
    R.R. Koganty et al., "GLYCOPEPTIDE-BASED AND CARBOHYDRATE-BASED SYNTHETIC VACCINES FOR THE IMMUNOTHERAPY OF CANCER", Drug discovery today, 1(5), 1996, pp. 190-198
24. MACLEAN GD; MILES DW; RUBENS RD; REDDISH MA; LONGENECKER BM
    ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE
    Journal of immunotherapy with emphasis on tumor immunology
    
    G.D. Maclean et al., "ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE", Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 309-316
25. MACLEAN GD; REDDISH MA; KOGANTY RR; LONGENECKER BM
    ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE
    Journal of immunotherapy with emphasis on tumor immunology
    
    G.D. Maclean et al., "ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE", Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 59-68
26. REDDISH MA; MACLEAN GD; POPPEMA S; BERG A; LONGENECKER BM
    PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL)
    Cancer immunology and immunotherapy
    
    M.A. Reddish et al., "PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL)", Cancer immunology and immunotherapy, 42(5), 1996, pp. 303-309
27. OBOYLE KP; MARKOWITZ AL; KHORSHIDI M; LALEZARI P; LONGENECKER BM; LLOYD KO; WELT S; WRIGHT KE
    SPECIFICITY ANALYSIS OF MURINE MONOCLONAL-ANTIBODIES REACTIVE WITH TN, SIALYLATED TN, T, AND MONOSIALYLATED (2-]6) T ANTIGENS
    Hybridoma
    
    K.P. Oboyle et al., "SPECIFICITY ANALYSIS OF MURINE MONOCLONAL-ANTIBODIES REACTIVE WITH TN, SIALYLATED TN, T, AND MONOSIALYLATED (2-]6) T ANTIGENS", Hybridoma, 15(6), 1996, pp. 401-408
28. AGRAWAL B; REDDISH M; LONGENECKER BM
    CD30 EXPRESSION ON HUMAN CD8-CELLS ISOLATED FROM PERIPHERAL-BLOOD LYMPHOCYTES OF NORMAL DONORS( T)
    The Journal of immunology
    
    B. Agrawal et al., "CD30 EXPRESSION ON HUMAN CD8-CELLS ISOLATED FROM PERIPHERAL-BLOOD LYMPHOCYTES OF NORMAL DONORS( T)", The Journal of immunology, 157(8), 1996, pp. 3229-3234
29. AGRAWAL B; REDDISH MA; LONGENECKER BM
    IN-VITRO INDUCTION OF MUC-1 PEPTIDE-SPECIFIC TYPE-1 T-LYMPHOCYTE AND CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM HEALTHY MULTIPAROUS DONORS
    The Journal of immunology
    
    B. Agrawal et al., "IN-VITRO INDUCTION OF MUC-1 PEPTIDE-SPECIFIC TYPE-1 T-LYMPHOCYTE AND CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM HEALTHY MULTIPAROUS DONORS", The Journal of immunology, 157(5), 1996, pp. 2089-2095
30. REGIMBALD LH; PILARSKI LM; LONGENECKER BM; REDDISH MA; ZIMMERMANN G; HUGH JC
    THE BREAST MUCIN MUC1 AS A NOVEL ADHESION LIGAND FOR ENDOTHELIAL INTERCELLULAR-ADHESION MOLECULE-1 IN BREAST-CANCER
    Cancer research
    
    L.H. Regimbald et al., "THE BREAST MUCIN MUC1 AS A NOVEL ADHESION LIGAND FOR ENDOTHELIAL INTERCELLULAR-ADHESION MOLECULE-1 IN BREAST-CANCER", Cancer research, 56(18), 1996, pp. 4244-4249
31. MILES DW; TOWLSON KE; GRAHAM R; REDDISH M; LONGENECKER BM; TAYLORPAPADIMITRIOU J; RUBENS RD
    A RANDOMIZED PHASE-II STUDY OF SIALYL-TN AND DETOX-B ADJUVANT WITH ORWITHOUT CYCLOPHOSPHAMIDE PRETREATMENT FOR THE ACTIVE SPECIFIC IMMUNOTHERAPY OF BREAST-CANCER
    British Journal of Cancer
    
    D.W. Miles et al., "A RANDOMIZED PHASE-II STUDY OF SIALYL-TN AND DETOX-B ADJUVANT WITH ORWITHOUT CYCLOPHOSPHAMIDE PRETREATMENT FOR THE ACTIVE SPECIFIC IMMUNOTHERAPY OF BREAST-CANCER", British Journal of Cancer, 74(8), 1996, pp. 1292-1296
32. YACYSHYN BR; LONGENECKER BM; BIERMANN WA; MCCLURE D; POPPEMA S; BOWENYACYSHYN MB
    ACTIVE SPECIFIC IMMUNOTHERAPY IN THE MANAGEMENT OF ADENOCARCINOMA OF THE PANCREAS
    Canadian journal of gastroenterology
    
    B.R. Yacyshyn et al., "ACTIVE SPECIFIC IMMUNOTHERAPY IN THE MANAGEMENT OF ADENOCARCINOMA OF THE PANCREAS", Canadian journal of gastroenterology, 9(4), 1995, pp. 213-216
33. REDDISH MA; BUSZYNSKI V; DING L; LONGENECKER BM
    ACTIVE SPECIFIC IMMUNOTHERAPY OF ADENOCARCINOMAS WITH SYNTHETIC TUMOR-ASSOCIATED ANTIGENS CONJUGATED TO KEYHOLE LIMPET HEMOCYANIN
    Onkologie
    
    M.A. Reddish et al., "ACTIVE SPECIFIC IMMUNOTHERAPY OF ADENOCARCINOMAS WITH SYNTHETIC TUMOR-ASSOCIATED ANTIGENS CONJUGATED TO KEYHOLE LIMPET HEMOCYANIN", Onkologie, 18, 1995, pp. 33-35
34. LIU XH; SEJBAL J; KOTOVYCH G; KOGANTY RR; REDDISH MA; JACKSON L; GANDHI SS; MENDONCA AJ; LONGENECKER BM
    STRUCTURALLY DEFINED SYNTHETIC CANCER VACCINES - ANALYSIS OF STRUCTURE, GLYCOSYLATION AND RECOGNITION OF CANCER-ASSOCIATED MUCIN, MUC-1 DERIVED PEPTIDES
    Glycoconjugate journal
    
    X.H. Liu et al., "STRUCTURALLY DEFINED SYNTHETIC CANCER VACCINES - ANALYSIS OF STRUCTURE, GLYCOSYLATION AND RECOGNITION OF CANCER-ASSOCIATED MUCIN, MUC-1 DERIVED PEPTIDES", Glycoconjugate journal, 12(5), 1995, pp. 607-617
35. YACYSHYN MBB; POPPEMA S; BERG A; MACLEAN GD; REDDISH MA; MEIKLE A; LONGENECKER BM
    CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA)
    International journal of cancer
    
    M.B.B. Yacyshyn et al., "CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA)", International journal of cancer, 61(4), 1995, pp. 470-474
36. ZHANG SL; WALBERG LA; OGATA S; ITZKOWITZ SH; KOGANTY RR; REDDISH M; GANDHI SS; LONGENECKER BM; LLOYD KO; LIVINGSTON PO
    IMMUNE SERA AND MONOCLONAL-ANTIBODIES DEFINE 2 CONFIGURATIONS FOR THESIALYL-TN TUMOR-ANTIGEN
    Cancer research
    
    S.L. Zhang et al., "IMMUNE SERA AND MONOCLONAL-ANTIBODIES DEFINE 2 CONFIGURATIONS FOR THESIALYL-TN TUMOR-ANTIGEN", Cancer research, 55(15), 1995, pp. 3364-3368
37. HELLING F; ZHANG S; SHANG A; ADLURI S; CALVES M; KOGANTY R; LONGENECKER BM; YAO TJ; OETTGEN HF; LIVINGSTON PO
    G(M2)-KLH CONJUGATE VACCINE - INCREASED IMMUNOGENICITY IN MELANOMA PATIENTS AFTER ADMINISTRATION WITH IMMUNOLOGICAL ADJUVANT QS-21
    Cancer research
    
    F. Helling et al., "G(M2)-KLH CONJUGATE VACCINE - INCREASED IMMUNOGENICITY IN MELANOMA PATIENTS AFTER ADMINISTRATION WITH IMMUNOLOGICAL ADJUVANT QS-21", Cancer research, 55(13), 1995, pp. 2783-2788
38. AGRAWAL B; REDDISH MA; KRANTZ MJ; LONGENECKER BM
    DOES PREGNANCY IMMUNIZE AGAINST BREAST-CANCER
    Cancer research
    
    B. Agrawal et al., "DOES PREGNANCY IMMUNIZE AGAINST BREAST-CANCER", Cancer research, 55(11), 1995, pp. 2257-2261
39. MACLEAN GD; LONGENECKER BM
    PROSPECTS FOR AN IMMUNOLOGICAL APPROACH TO THERAPY OF OVARIAN-CANCER
    CLINICAL IMMUNOTHERAPEUTICS
    
    G.D. Maclean e B.M. Longenecker, "PROSPECTS FOR AN IMMUNOLOGICAL APPROACH TO THERAPY OF OVARIAN-CANCER", CLINICAL IMMUNOTHERAPEUTICS, 2(6), 1994, pp. 409-414
40. MACLEAN GD; REDDISH MA; BOWENYACYSHYN MB; POPPEMA S; LONGENECKER BM
    ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS
    Cancer investigation
    
    G.D. Maclean et al., "ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS", Cancer investigation, 12(1), 1994, pp. 46-56
41. HO I; OGATA S; CHEN A; WEISS A; REDDISH M; LONGENECKER BM; ITZKOWITZ SH
    ADOPTIVE TRANSFER OF LYMPHOCYTES SENSITIZED TO SIALOSYL-TN(STN) ANTIGEN PROLONGS SURVIVAL IN RAT COLON-CANCER
    Gastroenterology
    
    I. Ho et al., "ADOPTIVE TRANSFER OF LYMPHOCYTES SENSITIZED TO SIALOSYL-TN(STN) ANTIGEN PROLONGS SURVIVAL IN RAT COLON-CANCER", Gastroenterology, 106(4), 1994, pp. 10000392-10000392
42. YACYSHYN BR; LONGENECKER BM; POPPEMA S; BOWENYACYSHYN MB
    ACTIVE SPECIFIC IMMUNOTHERAPY FOR PANCREATIC ADENOCARCINOMA
    Gastroenterology
    
    B.R. Yacyshyn et al., "ACTIVE SPECIFIC IMMUNOTHERAPY FOR PANCREATIC ADENOCARCINOMA", Gastroenterology, 106(4), 1994, pp. 10000452-10000452
43. MORO R; TAMAOKI T; WEGMANN TG; LONGENECKER BM; LADEROUTE MP
    MONOCLONAL-ANTIBODIES DIRECTED AGAINST A WIDESPREAD ONCOFETAL ANTIGEN- THE ALPHA-FETOPROTEIN RECEPTOR
    Tumor biology
    
    R. Moro et al., "MONOCLONAL-ANTIBODIES DIRECTED AGAINST A WIDESPREAD ONCOFETAL ANTIGEN- THE ALPHA-FETOPROTEIN RECEPTOR", Tumor biology, 14(2), 1993, pp. 116-130